EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis

Podeu consultar la correcció d'errades a: http://dx.doi.org/10.1136/annrheumdis-2016-209133corr1

Detalles Bibliográficos
Autores: Yates, M., Watts, Richard A., Bajema, I. M., Cid Xutglà, M. Cinta, Crestani, B., Hauser, T., Hellmich, B., Holle, Julia, Laudien, M., Little, M. A., Luqmani, R. A., Mahr, A., Merkel, Peter A., Mills, J., Mooney, J., Segelmark, Mårten, Tesar, V., Westman, K., Vaglio, Augusto, Yalçindag, N., Jayne, David, Mukhtyar, C.
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2016
País:España
Institución:Universidad de Barcelona
Repositorio:Dipòsit Digital de la UB
OAI Identifier:oai:diposit.ub.edu:2445/114993
Acceso en línea:https://hdl.handle.net/2445/114993
Access Level:acceso abierto
Palabra clave:Vasculitis
Vasos sanguinis
Protocols clínics
Corticosteroides
Blood vessels
Medical protocols
Adrenocortical hormones
id ES_081bd6fe6e5ccb2f50143aba3e0bbb66
oai_identifier_str oai:diposit.ub.edu:2445/114993
network_acronym_str ES
network_name_str España
repository_id_str
spelling EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitisYates, M.Watts, Richard A.Bajema, I. M.Cid Xutglà, M. CintaCrestani, B.Hauser, T.Hellmich, B.Holle, JuliaLaudien, M.Little, M. A.Luqmani, R. A.Mahr, A.Merkel, Peter A.Mills, J.Mooney, J.Segelmark, MårtenTesar, V.Westman, K.Vaglio, AugustoYalçindag, N.Jayne, DavidMukhtyar, C.VasculitisVasos sanguinisProtocols clínicsCorticosteroidesVasculitisBlood vesselsMedical protocolsAdrenocortical hormonesPodeu consultar la correcció d'errades a: http://dx.doi.org/10.1136/annrheumdis-2016-209133corr1In this article, the 2009 European League Against Rheumatism (EULAR) recommendations for the management of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) have been updated. The 2009 recommendations were on the management of primary small and medium vessel vasculitis. The 2015 update has been developed by an international task force representing EULAR, the European Renal Association and the European Vasculitis Society (EUVAS). The recommendations are based upon evidence from systematic literature reviews, as well as expert opinion where appropriate. The evidence presented was discussed and summarised by the experts in the course of a consensus-finding and voting process. Levels of evidence and grades of recommendations were derived and levels of agreement (strengths of recommendations) determined. In addition to the voting by the task force members, the relevance of the recommendations was assessed by an online voting survey among members of EUVAS. Fifteen recommendations were developed, covering general aspects, such as attaining remission and the need for shared decision making between clinicians and patients. More specific items relate to starting immunosuppressive therapy in combination with glucocorticoids to induce remission, followed by a period of remission maintenance; for remission induction in life-threatening or organ-threatening AAV, cyclophosphamide and rituximab are considered to have similar efficacy; plasma exchange which is recommended, where licensed, in the setting of rapidly progressive renal failure or severe diffuse pulmonary haemorrhage. These recommendations are intended for use by healthcare professionals, doctors in specialist training, medical students, pharmaceutical industries and drug regulatory organisations.BMJ Publishing Group2016info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://hdl.handle.net/2445/114993Articles publicats en revistes (Medicina)reponame:Dipòsit Digital de la UBinstname:Universidad de BarcelonaInglésReproducció del document publicat a: https://doi.org/10.1136/annrheumdis-2016-209133Annals of the Rheumatic Diseases, 2016, vol. 75, num. 9, p. 1583-1594https://doi.org/10.1136/annrheumdis-2016-209133http://dx.doi.org/10.1136/annrheumdis-2016-209133corr1(c) BMJ Publishing Group, 2016info:eu-repo/semantics/openAccessoai:diposit.ub.edu:2445/1149932026-05-27T06:46:51Z
dc.title.none.fl_str_mv EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis
title EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis
spellingShingle EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis
Yates, M.
Vasculitis
Vasos sanguinis
Protocols clínics
Corticosteroides
Vasculitis
Blood vessels
Medical protocols
Adrenocortical hormones
title_short EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis
title_full EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis
title_fullStr EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis
title_full_unstemmed EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis
title_sort EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis
dc.creator.none.fl_str_mv Yates, M.
Watts, Richard A.
Bajema, I. M.
Cid Xutglà, M. Cinta
Crestani, B.
Hauser, T.
Hellmich, B.
Holle, Julia
Laudien, M.
Little, M. A.
Luqmani, R. A.
Mahr, A.
Merkel, Peter A.
Mills, J.
Mooney, J.
Segelmark, Mårten
Tesar, V.
Westman, K.
Vaglio, Augusto
Yalçindag, N.
Jayne, David
Mukhtyar, C.
author Yates, M.
author_facet Yates, M.
Watts, Richard A.
Bajema, I. M.
Cid Xutglà, M. Cinta
Crestani, B.
Hauser, T.
Hellmich, B.
Holle, Julia
Laudien, M.
Little, M. A.
Luqmani, R. A.
Mahr, A.
Merkel, Peter A.
Mills, J.
Mooney, J.
Segelmark, Mårten
Tesar, V.
Westman, K.
Vaglio, Augusto
Yalçindag, N.
Jayne, David
Mukhtyar, C.
author_role author
author2 Watts, Richard A.
Bajema, I. M.
Cid Xutglà, M. Cinta
Crestani, B.
Hauser, T.
Hellmich, B.
Holle, Julia
Laudien, M.
Little, M. A.
Luqmani, R. A.
Mahr, A.
Merkel, Peter A.
Mills, J.
Mooney, J.
Segelmark, Mårten
Tesar, V.
Westman, K.
Vaglio, Augusto
Yalçindag, N.
Jayne, David
Mukhtyar, C.
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Vasculitis
Vasos sanguinis
Protocols clínics
Corticosteroides
Vasculitis
Blood vessels
Medical protocols
Adrenocortical hormones
topic Vasculitis
Vasos sanguinis
Protocols clínics
Corticosteroides
Vasculitis
Blood vessels
Medical protocols
Adrenocortical hormones
description Podeu consultar la correcció d'errades a: http://dx.doi.org/10.1136/annrheumdis-2016-209133corr1
publishDate 2016
dc.date.none.fl_str_mv 2016
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://hdl.handle.net/2445/114993
url https://hdl.handle.net/2445/114993
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv Reproducció del document publicat a: https://doi.org/10.1136/annrheumdis-2016-209133
Annals of the Rheumatic Diseases, 2016, vol. 75, num. 9, p. 1583-1594
https://doi.org/10.1136/annrheumdis-2016-209133
http://dx.doi.org/10.1136/annrheumdis-2016-209133corr1
dc.rights.none.fl_str_mv (c) BMJ Publishing Group, 2016
info:eu-repo/semantics/openAccess
rights_invalid_str_mv (c) BMJ Publishing Group, 2016
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv BMJ Publishing Group
publisher.none.fl_str_mv BMJ Publishing Group
dc.source.none.fl_str_mv Articles publicats en revistes (Medicina)
reponame:Dipòsit Digital de la UB
instname:Universidad de Barcelona
instname_str Universidad de Barcelona
reponame_str Dipòsit Digital de la UB
collection Dipòsit Digital de la UB
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869403023493562368
score 15,301603

Similares en LA Referencia